Literature DB >> 20096708

Possible expressions of radiation-induced genomic instability, bystander effects or low-dose hypersensitivity in cancer epidemiology.

Peter Jacob1, Reinhard Meckbach2, Jan Christian Kaiser2, Mikhail Sokolnikov3.   

Abstract

Recent publications on the integration of radiobiological effects in the two-step clonal expansion (TSCE) model of carcinogenesis and applications to radioepidemiological data are reviewed and updated. First, a model version with radiation-induced genomic instability was shown to be a possible explanation for the age dependence of the radiation-induced cancer mortality in the Techa River Cohort. Second, it is demonstrated that inclusion of a bystander effect with a dose threshold allows an improved description of the lung cancer mortality risk for the Mayak workers cohort due to incorporation of plutonium. The threshold for the annual lung dose is estimated to 12 (90%CI: 4; 14)mGy/year. This threshold applies to the initiation of preneoplastic cells and to hyperplastic growth. There is, however, no evidence for a threshold for the effects of gamma radiation. Third, models with radiation-induced cell inactivation tend to predict lower cancer risks among the atomic bomb survivors with exposure at young age than conventionally used empirical models. Also, risks after exposures with doses in the order of 100mGy are predicted to be higher in models with low-dose hypersensitivity than in models with conventional cell survival curves. In the reviewed literature, models of carcinogenesis tend to describe radioepidemiological data better than conventionally used empirical models. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096708     DOI: 10.1016/j.mrfmmm.2010.01.005

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  8 in total

1.  Breast cancer risk in atomic bomb survivors from multi-model inference with incidence data 1958-1998.

Authors:  J C Kaiser; P Jacob; R Meckbach; H M Cullings
Journal:  Radiat Environ Biophys       Date:  2011-09-23       Impact factor: 1.925

2.  Elucidation of changes in molecular signalling leading to increased cellular transformation in oncogenically progressed human bronchial epithelial cells exposed to radiations of increasing LET.

Authors:  Liang-Hao Ding; Seongmi Park; Yang Xie; Luc Girard; John D Minna; Michael D Story
Journal:  Mutagenesis       Date:  2015-05-22       Impact factor: 3.000

3.  Lung cancer mortality (1950-1999) among Eldorado uranium workers: a comparison of models of carcinogenesis and empirical excess risk models.

Authors:  Markus Eidemüller; Peter Jacob; Rachel S D Lane; Stanley E Frost; Lydia B Zablotska
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

4.  Beyond two-stage models for lung carcinogenesis in the Mayak workers: implications for plutonium risk.

Authors:  Sascha Zöllner; Mikhail E Sokolnikov; Markus Eidemüller
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

5.  Genomic instability and radiation risk in molecular pathways to colon cancer.

Authors:  Jan Christian Kaiser; Reinhard Meckbach; Peter Jacob
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

Review 6.  Cancer risk assessment in modern radiotherapy workflow with medical big data.

Authors:  Fu Jin; Huan-Li Luo; Juan Zhou; Ya-Nan He; Xian-Feng Liu; Ming-Song Zhong; Han Yang; Chao Li; Qi-Cheng Li; Xia Huang; Xiu-Mei Tian; Da Qiu; Guang-Lei He; Li Yin; Ying Wang
Journal:  Cancer Manag Res       Date:  2018-06-22       Impact factor: 3.989

Review 7.  REVIEW OF QUANTITATIVE MECHANISTIC MODELS OF RADIATION-INDUCED NON-TARGETED EFFECTS (NTE).

Authors:  Igor Shuryak; David J Brenner
Journal:  Radiat Prot Dosimetry       Date:  2020-12-30       Impact factor: 0.972

Review 8.  Colorectal Carcinogenesis, Radiation Quality, and the Ubiquitin-Proteasome Pathway.

Authors:  Kamal Datta; Shubhankar Suman; Santosh Kumar; Albert J Fornace
Journal:  J Cancer       Date:  2016-01-01       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.